2094. Acceptability of Antibiotic Substitutions for Fluoroquinolones and Third and Fourth-generation Cephalosporins: A Report from the VA-CDC Practice-Based Research Network (PBRN)

BACKGROUND: Studies suggest fluoroquinolones (FQ), and third (3C) and fourth (4C) generation cephalosporins, agents often used for empiric therapy, place patients at higher risk for C. difficile infection. Substituting alternative antibiotics for empiric therapy might reduce risk. We surveyed inpati...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Goetz, Matthew B, Hockett Sherlock, Stacey, Goedken, Cassie, Balkenende, Erin C, Evans, Charlesnika T, Perencevich, Eli, Echevarria, Kelly, Reddy, Sujan, Neuhauser, Melinda M, Reisinger, Heather, Suda, Katie J
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809126/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1774
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料